Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Rank in Stocks #27452
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Share Price
$1.62
Last synced: 2026-08-19
Market Cap
$32.77M
Change (1 day)
22.67%
Change (1 year)
-13.87%
Country
US
Trade AIxCrypto Holdings, Inc. (AIXC)

Category

Stock price history for AIxCrypto Holdings, Inc. (AIXC)
Highest end of day price: $0.90 on 2026-08-01

Lowest end of day price: $589.38K on 2015-06-01
Stock price history of AIxCrypto Holdings, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$61.63 67.11%
US
$51.71 74.55%
SE
$196.66 45.99%
FR
$119.62 69.92%
US
$62.87 2.86%
IT